Label: SELENIUM SULFIDE lotion
-
Contains inactivated NDC Code(s)
NDC Code(s): 76413-123-01 - Packager: Central Texas Community Health Centers
- This is a repackaged label.
- Source NDC Code(s): 60432-528
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated January 25, 2016
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
-
APPLICATION INSTRUCTIONS
Keep tightly capped. SHAKE WELL BEFORE USING. Product may damage jewelry; remove jewelry before use.
For treatment of tinea versicolor:
- Apply to affected areas and lather with a small amount of water.
- Allow to remain on skin for 10 minutes.
- Rinse body thoroughly.
- Repeat this procedure once a day for 7 days.
For treatment of dandruff and seborrheic dermatitis of the scalp.
- Massage 1 or 2 teaspoonfuls of shampoo into wet scalp.
- Allow to remain on scalp for 2 to 3 minutes.
- Rinse scalp thoroughly.
- Repeat application and rinse thoroughly.
- After treatment, wash hands well.
- Repeat treatments as directed by physician.
-
WARNINGS AND PRECAUTIONS:
For External Use Only. Do not use on broken skin or inflamed areas. If allergic reactions occur, discontinue use. Avoid getting shampoo in eyes or in contact with genital area as it may cause irritation and burning.
FOR EXTERNAL USE ONLY. WARNING: KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
- STORAGE AND HANDLING
-
CLINICAL PHARMACOLOGY:
Selenium sulfide appears to have a cytostatic effect on cells of the epidermis and follicular epithelium, reducing corneocyte production.
INDICATIONS AND USAGE:
For treatment of tinea versicolor, seborrheic dermatitis of scalp and treatment of dandruff.
PRECAUTIONS:
General:
Not to be used when acute inflammation or exudation is present as increased absorption may occur.
Carcinogenesis:
Dermal application of 25% and 50% solutions of 2.5% selenium sulfide lotion on mice over an 88 week period, indicated no carcinogenic effects.
Pregnancy:
WHEN USED ON BODY SURFACES FOR THE TREATMENT OF TINEA VERSICOLOR, SELENIUM SULFIDE LOTION, USP 2.5% IS CLASSIFIED AS PREGNANCY CATEGORY C. Animal reproduction studies have not been conducted with selenium sulfide. It is also not known whether selenium sulfide can cause fetal harm when applied to body surfaces of a pregnant woman or can affect reproduction capacity. Under ordinary circumstances selenium sulfide should not be used for the treatment of tinea versicolor in pregnant women.
-
OVERDOSAGE:
Accidental Oral Ingestion:
No documented reports of serious toxicity in humans resulting from acute ingestion of selenium sulfide, however, acute toxicity studies in animals suggest that ingestion of large amounts could result in potential human toxicity. Evacuation of the stomach contents should be considered in cases of acute oral ingestion.
- DOSAGE AND ADMINISTRATION:
- For treatment of tinea versicolor:
- For treatment of dandruff and seborrheic dermatitis:
- HOW SUPPLIED
- WARNINGS
- SPL UNCLASSIFIED SECTION
-
PRINCIPAL DISPLAY PANEL - 118 ML Bottle Label
CommUnityCare Federally Qualified Health Centers
SELENIUM
SULFIDE
2.5 %
LOTIONDate:
Name:
Dr.SHAKE WELL AND USE AS DIRECTED BY DOCTOR**FOR
EXTERNAL USE ONLY**lot number
exp date
SELENIUM SULFIDE 2.5% LOTION 118ML NDC 76413-123-01
Batch. batch number
Lot: lot number
Exp: exp date
MGPFederal law prohibits the transfer of this drug to any other person than the patient for whom prescribed.
-
INGREDIENTS AND APPEARANCE
SELENIUM SULFIDE
selenium sulfide lotionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:76413-123(NDC:60432-528) Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Selenium Sulfide (UNII: Z69D9E381Q) (Selenium Sulfide - UNII:Z69D9E381Q) Selenium Sulfide 25 mg in 1 mL Inactive Ingredients Ingredient Name Strength BENTONITE (UNII: A3N5ZCN45C) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) WATER (UNII: 059QF0KO0R) ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) SODIUM PHOSPHATE, MONOBASIC (UNII: 3980JIH2SW) SODIUM LAURYL SULFATE (UNII: 368GB5141J) DISODIUM COCOAMPHODIACETATE (UNII: 18L9G3U51M) GLYCOL STEARATE (UNII: 0324G66D0E) LAURIC DIETHANOLAMIDE (UNII: I29I2VHG38) CASTOR OIL (UNII: D5340Y2I9G) CAPTAN (UNII: EOL5G26Q9F) D&C YELLOW NO. 10 (UNII: 35SW5USQ3G) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:76413-123-01 118 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA088228 09/01/1983 Labeler - Central Texas Community Health Centers (079674019) Establishment Name Address ID/FEI Business Operations Central Texas Community Health Centers 079674019 REPACK(76413-123) , RELABEL(76413-123)